Role of 12-lipoxygenase in Platelet Reactivity and Type 2 Diabetes Mellitus

计划入组 90 人 · 首次发布于 2015 年 12 月 14 日

Study of the Arachidonate 5-Lipoxygenase Enzyme in Affecting the Risk for Coronary Heart Disease

计划入组 22 人 · 首次发布于 2006 年 9 月 22 日

Molecular Targeting of 15-Lipoxygenase-1 (15-LOX-1) for Apoptosis Induction in Human Colorectal Cancers

计划入组 51 人 · 首次发布于 2007 年 7 月 18 日

3323W

12-Hydroxydodecanoic Acid

C₁₂H₂₄O₃

5-lipoxygenase activating protein inhibitors (Janssen)

上海生诺医药科技有限公司

Microvascular Therapeutics LLC

United States

Altair Therapeutics, Inc.

United States

Cadrenal Therapeutics Acquires First-in-Class 12-LOX Inhibitor VLX-1005 for Heparin-Induced Thrombocytopenia Treatment

GSK Secures $12 Billion Partnership with Hengrui for 12-Drug Development Portfolio

Trump Administration Reshapes Health Agencies; FDA Approves Novel Cancer Therapies